CING
Cingulate Inc
NASDAQ: CING · HEALTHCARE · BIOTECHNOLOGY
$4.71
+0.64% today
Updated 2026-04-29
Market cap
$67.01M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.44
Dividend yield
—
52W range
$3 – $12
Volume
0.5M
Cingulate Inc (CING) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-34.3%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+77.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-21.9%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-35.6%
2026-03-18
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-18 | $-0.84 | +45.8% | $11.66 | $7.51 | -35.6% |
| 2025-11-13 | $-1.35 | -42.1% | $3.80 | $3.49 | -8.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.55 | $-0.84 | +45.8% | — | — |
| 2025-09-30 | $-0.95 | $-1.35 | -42.1% | — | — |
| 2025-06-30 | $-0.93 | $-2.14 | -130.1% | — | — |
| 2025-03-31 | $-0.94 | $-1.04 | -10.6% | — | — |
| 2024-12-31 | $-2.93 | $-3.68 | -25.6% | $12.98B | — |
| 2024-09-30 | $-2.22 | $-1.83 | +17.6% | — | — |
| 2024-06-30 | $-4.92 | $-5.47 | -11.2% | — | — |
| 2024-03-31 | $-12.48 | $-7.20 | +42.3% | $-3.85B | -200.0% |
| 2023-12-31 | $-4.86 | $-7.66 | -57.6% | — | — |
| 2023-09-30 | $-0.37 | $-0.30 | +18.9% | — | — |
| 2023-06-30 | $-0.35 | $-0.57 | -62.9% | — | — |
| 2023-03-31 | $-0.34 | $-0.35 | -2.9% | $3.85B | — |
Frequently asked questions
Has Cingulate Inc beaten earnings estimates?
Cingulate Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -34.3% over the last 4 quarters.
How does CING stock react to earnings?
CING stock has moved an average of -21.9% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.